NASDAQ
Agenus Inc. (AGEN)
♥ 563 Thanks from members
Agenus Inc. (AGEN) presents a classic biotech crossroads, balancing high-stakes potential from its lead immuno-oncology combination BOT+BAL against persistent balance sheet pressures and going concern warnings despite recent capital raises.